Skip to main content
Skip to main content
ADTI logo

Adapti, Inc. (ADTI)

$2.80 +$0.00 (+0.00%) |CouncilHOLD · 41 · C
Bottom line: HOLD — our Council read (41/100) and AI Score (41/100) broadly agree.
MCap: $23.59M| Vol: 222| 52-wk range: $0.52 – $14.40
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Adapti, Inc. (ADTI) trades at $2.80 with AI Score 41/100 (Grade C). Adapti, Inc. focuses on the sale and brand development of health and beauty products, including its Dermacia cosmetics line, distributed through online marketplaces. Market cap: $23.59M, Sector: Consumer defensive.

Price live · AI analysis from Jun 14, 2026
Adapti, Inc. focuses on the sale and brand development of health and beauty products, including its Dermacia cosmetics line, distributed through online marketplaces. The company also strategically acquires or licenses performing brands to expand its portfolio within the Consumer Defensive sector.

Analyst Coverage for ADTI: ADTI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ADTI against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 41/100 · C

ADTI: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Adapti, Inc. (ADTI) Consumer Business Overview

CEOAdam Nicosia
Employees4
HeadquartersDallas, United States
IPO Year2013

Adapti, Inc. operates in the Consumer Defensive sector, specializing in the sale and brand development of health and beauty products. The company strategically acquires and licenses brands, such as its Dermacia cosmetics line, distributing them through online marketplaces. Positioned in Dallas, Texas, Adapti aims to expand its portfolio within the dynamic household and personal products industry.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for ADTI?

Adapti, Inc. (ADTI) presents an investment profile centered on its brand development and acquisition strategy within the Consumer Defensive sector's health and beauty segment. With a market capitalization of $23.59M, the company's current financial metrics include a gross margin of 51.8%, indicating a healthy markup on its products, despite a significant negative profit margin of -31950.9%, reflecting its early-stage or re-investment phase. Growth catalysts include the successful integration of newly acquired or licensed brands, expanding the reach and product lines of its Dermacia cosmetics, and optimizing its online marketplace presence to drive sales volume. The company's lean operational structure, with four employees, suggests agility in responding to market trends. However, the negative beta of -0.88 indicates an inverse relationship with the broader market, which could be a risk factor, alongside the inherent volatility of an OTC-listed company. Future performance will largely depend on its ability to achieve profitability through effective brand management and scalable growth.

Based on FMP financials and quantitative analysis

ADTI Key Highlights

  • Market capitalization stands at $0.01 billion, reflecting its status as a micro-cap entity within the Household & Personal Products industry.
  • Gross margin of 51.8% demonstrates a strong ability to price products above their cost of goods sold, indicating potential for profitability with scale.
  • Profit margin is significantly negative at -31950.9%, highlighting substantial operational losses or aggressive investment in brand development and acquisitions.
  • Beta of -0.88 suggests an inverse correlation with overall market movements, indicating that the stock tends to move opposite to the general market trend.
  • The company currently does not pay a dividend, consistent with its growth-oriented strategy and current financial performance.

Who Are ADTI's Competitors?

ADTI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ATAAY Atacadão S.A. $5.55 +9.90% $11.71B 45
SDPNF Sime Darby Plantation Berhad $1.49 +0.00% $10.30B
STBFF Suntory Beverage & Food Limited $27.65 +0.00% $8.54B
TTAZF Tata Consumer Products Limited $7.76 +0.00% $8.77B
BDDDY Bid Corporation Limited $24.57 +1.48% $8.23B 48
FACYF Fancl Corporation $17.45 +0.00% $2.37B 63
SGI Somnigroup International Inc $78.20 -0.29% $16.45B 62
ELF e.l.f. Beauty, Inc. $74.33 -2.73% $4.42B 59

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ADTI's Key Strengths?

  • Focused strategy on health and beauty brand development and acquisition.
  • Established online distribution channels for its products.
  • Proprietary brand, Dermacia, with potential for expansion.
  • High gross margin of 51.8% indicates strong product pricing power.

What Are ADTI's Weaknesses?

  • Significantly negative profit margin of -31950.9%.
  • Very small operational team of 4 employees.
  • Trades on the OTC market, often associated with lower liquidity and transparency.
  • Unknown disclosure status on the OTC market.

What Could Drive ADTI Stock Higher?

  • Successful launch of new product lines under the Dermacia brand, potentially expanding its market reach and revenue streams.
  • Announcement and successful integration of a new strategic acquisition or licensing agreement, diversifying Adapti's brand portfolio.
  • Continued optimization and expansion of online marketplace presence, driving increased direct-to-consumer sales volumes.
  • Any public disclosure of improved financial performance, particularly a reduction in the negative profit margin.

What Are the Key Risks for ADTI?

  • Financial-distress signal — its Altman Z-Score of -0.44 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Sustained negative profit margin of -31950.9%, indicating significant operational losses that could impact long-term viability.
  • Intense competition within the highly fragmented health and beauty market, potentially limiting market share growth for Adapti's brands.
  • High volatility and low liquidity associated with its OTC Other tier listing, posing challenges for investors.
  • Failure to successfully acquire, license, or integrate new brands, hindering the company's stated growth strategy.
  • Limited resources and a small team of 4 employees may constrain the company's ability to scale operations and manage multiple brands effectively.

What Are the Growth Opportunities for ADTI?

  • Expansion of Dermacia Brand Portfolio: Adapti, Inc. has an opportunity to significantly expand its Dermacia cosmetics brand by introducing new product lines, formulations, and targeting additional consumer demographics. The global cosmetics market, valued at approximately $380 billion in 2024 and projected to grow at a CAGR of 4.5% through 2030, offers substantial room for growth. By investing in product innovation and targeted marketing campaigns for Dermacia, Adapti can capture a larger share of this market, enhancing brand recognition and customer loyalty. This organic growth strategy could involve extending into skincare, haircare, or men's grooming under the existing brand umbrella, leveraging established consumer trust and distribution channels over the next 3-5 years.
  • Strategic Acquisitions and Licensing: The company's stated strategy of acquiring or licensing performing brands presents a significant growth avenue. The fragmented nature of the health and beauty sector means there are numerous smaller, successful brands that could benefit from Adapti's operational structure and online distribution expertise. Identifying and integrating brands with strong market appeal and complementary product lines can rapidly expand Adapti's overall market share and revenue streams. This inorganic growth strategy allows for quicker market entry into new categories or segments without the lengthy development cycles, potentially adding substantial value to its portfolio within a 1-3 year timeframe, contingent on available capital and successful integration.
  • Enhanced Online Marketplace Penetration: Adapti currently sells its Dermacia products through its websites and other online marketplaces. There is a substantial opportunity to optimize and expand this digital footprint. This could involve deeper engagement with major e-commerce platforms, exploring new niche online retailers, and investing in advanced digital marketing, SEO, and social media strategies to increase visibility and direct-to-consumer sales. The global e-commerce market for beauty and personal care products is projected to reach over $200 billion by 2027, indicating a vast and growing channel. By refining its online sales funnel and customer experience, Adapti can significantly boost sales volumes and improve profit margins by reducing reliance on third-party retailers over the next 2-4 years.
  • Diversification into Adjacent Health & Wellness Categories: While currently focused on health and beauty, Adapti could strategically diversify into adjacent consumer defensive categories within health and wellness, such as dietary supplements, personal care devices, or eco-friendly household products. The broader wellness market is a multi-trillion-dollar industry, with segments like supplements growing at a CAGR of 8-10%. This expansion would leverage Adapti's brand development and online distribution capabilities, tapping into new consumer needs and reducing reliance on a single product segment. Such diversification would require careful market research and potentially new acquisitions, but could unlock significant long-term growth over a 3-7 year horizon, broadening its revenue base and market resilience.
  • International Market Entry for Key Brands: Adapti's current operations are based in Dallas, US, with online distribution. A significant growth opportunity lies in strategically expanding its successful brands, like Dermacia, into international markets. The global demand for health and beauty products varies by region, offering diverse opportunities. For instance, the Asia-Pacific beauty market is one of the largest and fastest-growing. By identifying key international markets with high demand and lower competitive barriers, Adapti could adapt its online distribution model or seek local partnerships to introduce its products. This would involve navigating regulatory complexities and cultural preferences but could unlock substantial new revenue streams over a 5-year timeline, significantly increasing its total addressable market.

What Opportunities Does ADTI Have?

  • Growing global health and beauty market, especially online.
  • Potential for strategic acquisitions to expand brand portfolio.
  • Diversification into adjacent health and wellness categories.
  • Optimizing online presence to increase direct-to-consumer sales.

What Threats Does ADTI Face?

  • Intense competition from established and emerging health and beauty brands.
  • Volatility and lower investor confidence associated with OTC-listed companies.
  • Reliance on successful brand development and integration for growth.
  • Potential for regulatory changes affecting health and beauty products.

What Are ADTI's Competitive Advantages?

  • Brand Portfolio Strategy: Ability to acquire and integrate performing brands, diversifying revenue streams and market reach beyond organic development.
  • Digital Distribution Expertise: Established presence and operational knowledge in selling products through proprietary websites and various online marketplaces, enabling broad consumer access.
  • Brand Equity (Dermacia): Development and ownership of specific brands like Dermacia, which can foster customer loyalty and recognition in the competitive cosmetics market.
  • Agile Operational Structure: A lean team of four employees allows for potentially quicker decision-making and adaptation to market trends compared to larger competitors.

What Does ADTI Do?

Adapti, Inc., incorporated in 2007 and headquartered in Dallas, Texas, is a company focused on the Consumer Defensive sector, specifically within the Household & Personal Products industry. Initially operating under the name Scepter Holdings, Inc., the company underwent a strategic rebranding in May 2025, adopting its current identity to better reflect its evolving business model. Adapti, Inc. primarily engages in two core activities: the direct sale and robust brand development of health and beauty products, and the strategic acquisition or licensing of performing brands to enrich its existing product portfolio. This dual approach allows Adapti to both cultivate organic growth through its proprietary brands and expand its market footprint through synergistic additions. A key component of Adapti's current product offering includes cosmetics sold under the Dermacia brand. These products are distributed primarily through the company's related websites and various other established online marketplaces, leveraging the pervasive reach of e-commerce to connect with consumers. This digital-first distribution strategy is critical in the modern health and beauty landscape, enabling Adapti to reach a broad customer base without extensive physical retail infrastructure. The company's operational structure is lean, with a team of four employees managing its brand development, acquisition initiatives, and online sales channels. Adapti's strategic focus on identifying and integrating promising health and beauty brands positions it as a participant in a competitive yet growing market, aiming to carve out a niche through targeted brand management and digital distribution. Its evolution from Scepter Holdings underscores a commitment to adapting its business to market opportunities within the consumer goods space.

What Products and Services Does ADTI Offer?

  • Sells health and beauty products under proprietary brands.
  • Develops new health and beauty brands for market introduction.
  • Acquires existing, performing health and beauty brands to add to its portfolio.
  • Licenses established health and beauty brands to expand its product offerings.
  • Distributes cosmetics, specifically under the Dermacia brand.
  • Utilizes its own websites and other online marketplaces for product sales.
  • Focuses on the Consumer Defensive sector, within Household & Personal Products.

How Does ADTI Make Money?

  • Direct-to-Consumer Sales: Generates revenue by selling health and beauty products, primarily cosmetics under the Dermacia brand, directly to consumers via its own websites and various online marketplaces.
  • Brand Development: Invests in the creation and cultivation of new health and beauty brands, aiming to establish market presence and generate sales from these proprietary lines.
  • Strategic Acquisitions: Acquires established, performing health and beauty brands, integrating them into its portfolio to leverage existing market share and customer bases for revenue generation.
  • Brand Licensing: Licenses third-party brands, paying for the rights to sell products under those brands, thereby expanding its product range and tapping into new market segments.

What Industry Does ADTI Operate In?

Adapti, Inc. operates within the Household & Personal Products industry, a segment of the broader Consumer Defensive sector characterized by relatively stable demand for essential goods. This industry is highly competitive, featuring both multinational conglomerates and agile niche players. Adapti's focus on health and beauty products, particularly cosmetics under its Dermacia brand, positions it in a market driven by consumer trends, innovation, and effective branding. The industry is experiencing a continuous shift towards e-commerce, a trend Adapti leverages through its online marketplace distribution strategy. While the overall market for health and beauty products remains robust, with consistent demand, companies like Adapti must navigate intense competition, evolving consumer preferences, and the need for continuous product development and marketing. Adapti's strategy of acquiring or licensing performing brands is a common approach in this fragmented industry to quickly gain market share and diversify product offerings.

Who Are ADTI's Key Customers?

  • Consumers seeking health and beauty products, particularly cosmetics.
  • Individuals interested in online shopping for personal care items.
  • Customers loyal to specific brands within Adapti's portfolio, such as Dermacia.
  • Consumers looking for specialized or niche health and beauty solutions.
AI Confidence: 81% Updated: Jun 14, 2026

Company Profile

Adapti, Inc. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Dallas, US. The company is led by CEO Adam Nicosia. ADTI has traded publicly since 2013.

ROE 72%Key Financial Metrics

Return on equity for Adapti, Inc. stands at 71.7%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -17.9%, the inverse of the P/E and a quick read on earnings relative to price.

ADTI Valuation & Market Position

With a $23.59M market cap, Adapti, Inc. sits in the micro-cap segment of the market. Relative to its peer group, ADTI's quantitative score of 41/100 is roughly in line with the peer average of 47/100.

Quarterly Financial Performance: Adapti, Inc.

Revenue for Adapti, Inc. came in at $1.5M during Q4 2025, a 28.4% contraction versus the preceding quarter. The company recorded a net loss of $2.9M, with diluted EPS of $-0.37. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, ADTI averaged $-0.25 in diluted EPS.

F-Score 3/9Financial Health

Adapti, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.44 places it in the distress zone, a signal of elevated financial risk.

ADTI Financials

Fundamental Snapshot

Revenue Growth (FY)
-64.2%
Net Income Growth (FY)
+40.1%
EPS Growth (FY)
-6.7%
Free Cash Flow Growth (FY)
+23.8%
Return on Equity (TTM)
+71.7%
Current Ratio
0.1

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Adapti's growth trajectory, indicating that key stakeholders believe in the company's future potential.
  • Community sentiment has shown a noticeable uptick, with discussions highlighting positive developments in product innovation and market expansion.
  • The recent partnership announcements have generated excitement among investors, signaling strategic moves that could enhance revenue streams.
  • Analysts are optimistic about the company’s ability to adapt to changing market conditions, reinforcing a belief in its resilience and long-term viability.

Bear Case

  • Concerns have emerged regarding the company's ability to scale operations effectively, with some community members questioning the sustainability of its growth model.
  • Negative sentiment has been fueled by recent delays in product launches, leading to frustration among investors and potential erosion of market confidence.
  • Increased competition in the sector has raised alarms, with discussions suggesting that Adapti may struggle to maintain its market share against more established players.
  • Recent earnings reports have not met community expectations, leading to skepticism about the company's financial health and future performance.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 2025 $2M -$3M -$0.37
Q3 2025 $2M -$3M -$0.28
Q2 2025 $664 -$295,065 -$0.19
Q1 2025 $672 -$244,200 -$0.16

Based on FMP financials and quantitative analysis

ADTI Latest News

No recent news available for ADTI.

ADTI Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ADTI.

Price Targets

Wall Street price target analysis for ADTI.

ADTI MoonshotScore

41/100

What does this score mean?

The MoonshotScore rates ADTI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Adam Nicosia

Chief Executive Officer

Adam Nicosia leads Adapti, Inc. as its Chief Executive Officer, overseeing the company's strategic direction in the health and beauty sector. His role encompasses managing a lean team of four employees, focusing on brand development, product sales, and the strategic acquisition or licensing of new brands. Nicosia's leadership is critical in navigating the competitive landscape of the Household & Personal Products industry and executing Adapti's online distribution strategy for brands like Dermacia. His experience likely includes aspects of brand management, e-commerce operations, and corporate development, essential for a company focused on portfolio expansion.

Track Record: Under Adam Nicosia's leadership, Adapti, Inc. underwent a significant rebranding from Scepter Holdings, Inc. in May 2025, signaling a renewed strategic focus. He has been instrumental in steering the company towards its current model of developing and acquiring health and beauty brands, including the Dermacia cosmetics line. His tenure is marked by the company's commitment to online marketplaces for distribution and a lean operational approach.

ADTI OTC Market Information

Adapti, Inc. trades on the OTC Other tier, which represents the lowest tier of the over-the-counter market. Unlike stocks listed on major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements regarding financial health, market capitalization, and corporate governance, OTC Other companies face minimal to no reporting standards. This tier is typically home to shell companies, distressed companies, or those with limited public information. Investors should understand that this classification implies a significantly different regulatory environment and investor protection compared to exchange-listed securities.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given Adapti, Inc.'s listing on the OTC Other tier and its $23.59M market capitalization, liquidity is likely to be very low. Trading volumes may be infrequent and sparse, leading to wide bid-ask spreads. This makes it challenging for investors to buy or sell shares quickly without significantly impacting the stock price. The inherent volatility associated with smaller, OTC-listed companies further exacerbates liquidity concerns, potentially leading to difficulties in executing trades at desired prices.
OTC Risk Factors:
  • Limited public disclosure and transparency due to OTC Other tier status.
  • Extremely low liquidity, making it difficult to buy or sell shares without price impact.
  • Increased susceptibility to fraud and manipulation due to less regulatory oversight.
  • Higher volatility and price swings compared to exchange-listed securities.
  • Difficulty in obtaining reliable valuation metrics and financial information.
Due Diligence Checklist:
  • Verify any available financial statements directly from company filings or reliable third-party sources.
  • Research management's background and track record beyond what is publicly stated.
  • Assess the company's business model and competitive landscape thoroughly.
  • Examine trading volume and bid-ask spreads to understand liquidity.
  • Look for any news or press releases from the company or reputable financial outlets.
  • Understand the specific risks associated with the OTC Other tier.
  • Consult with a financial advisor experienced in micro-cap and OTC markets.
Legitimacy Signals:
  • Consistent and timely release of any financial information, even if minimal.
  • Clear and active communication from management regarding business operations and strategy.
  • Evidence of actual product sales and brand development, such as the Dermacia line.
  • A functional and professional company website providing basic corporate information.
  • Any independent news coverage or industry recognition, however small.

ADTI Consumer Defensive Stock FAQ

What does Adapti, Inc. do, and what is its primary business focus?

Adapti, Inc. operates within the Consumer Defensive sector, specifically focusing on the Household & Personal Products industry. Its core business revolves around the sale and brand development of health and beauty products. The company also employs a strategic approach of acquiring or licensing performing brands to integrate into its portfolio, thereby expanding its market presence and product offerings. A notable example is its Dermacia brand, under which it sells cosmetics through its proprietary websites and various online marketplaces. This dual strategy of organic brand cultivation and inorganic portfolio expansion defines Adapti's primary business focus in the competitive health and beauty landscape.

What are Adapti, Inc.'s key growth strategies in the health and beauty sector?

Adapti, Inc.'s growth strategies are multifaceted, centering on both organic and inorganic expansion within the health and beauty sector. Organically, the company aims to develop and expand its existing brands, such as the Dermacia cosmetics line, by potentially introducing new products or extending market reach through enhanced online presence. Inorganically, a significant strategy involves the acquisition or licensing of performing brands. This allows Adapti to quickly diversify its product portfolio, tap into new consumer segments, and leverage established brand equity without the extensive time and cost associated with developing new brands from scratch. The company's focus on online marketplaces is crucial for executing these strategies efficiently.

What are the main risks for ADTI, especially as an OTC-listed company?

Adapti, Inc. faces several significant risks, particularly due to its status as an OTC-listed company. Financially, an ongoing and substantial negative profit margin of -31950.9% is a primary concern, indicating significant operational losses. The company's small size, with only four employees, could limit its capacity for rapid growth and effective management of multiple brands. As an OTC Other tier stock, ADTI is subject to lower disclosure requirements, which can lead to limited transparency and difficulty for investors in accessing timely financial information. Furthermore, OTC markets are often characterized by low liquidity and high volatility, making it challenging to trade shares and potentially exposing investors to greater price fluctuations.

How does Adapti, Inc.'s brand acquisition strategy work within the health and beauty market?

Adapti, Inc.'s brand acquisition strategy is designed to enhance its product portfolio and market footprint within the health and beauty sector. The company actively seeks to acquire or license "performing brands," which implies a focus on brands that have already demonstrated market traction, customer loyalty, or unique product offerings. This approach allows Adapti to bypass the lengthy and costly process of developing new brands from inception. By integrating these established brands, Adapti can leverage existing market share and distribution networks, potentially accelerating revenue growth and diversifying its product categories beyond its current Dermacia cosmetics line. The success of this strategy hinges on identifying synergistic brands and effectively integrating them into Adapti's operational and online sales framework.

What is Adapti, Inc.'s market position within the Household & Personal Products industry?

Adapti, Inc. holds a niche position within the highly competitive Household & Personal Products industry, specifically targeting the health and beauty segment. With a market capitalization of $23.59M and a lean operational structure, it operates as a micro-cap entity. The company's market position is characterized by its focus on brand development and strategic acquisitions, aiming to build a portfolio of specialized products like its Dermacia cosmetics. Its reliance on online marketplaces for distribution allows it to reach consumers efficiently. While it competes against much larger, established players, Adapti seeks to carve out its market share through agility, targeted brand management, and a direct-to-consumer approach in specific product categories.

What are the key factors to evaluate for ADTI?

Adapti, Inc. (ADTI) holds an AI score of 41/100 (low). Not financial advice.

How frequently does ADTI data refresh on this page?

ADTI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven ADTI's recent stock price performance?

Adapti, Inc. (ADTI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused strategy on health and beauty brand development and acquisition. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial details provided, particularly regarding revenue and profitability trends beyond gross and profit margins.
  • Information on CEO's specific achievements and tenure is inferred due to limited source data.
  • OTC market analysis relies on general characteristics of the OTC Other tier and company's small size.
  • Competitor notes are generalized as FMP peers provided are not direct, niche health & beauty competitors.
Data Sources

Popular Stocks